https://www.selleckchem.com/pr....oducts/FK-506-(Tacro
01, 95%CI = 0.78-1.30, p = 0.96) whether it is for SG (OR = 1.25, 95%CI = 0.73-2.14, p = 0.42) or RYGB (OR = 0.94, 95%CI = 0.71-1.26, p = 0.69) and for major postoperative morbidity (OR = 0.96, 95%CI = 0.59-1.56, p = 0.87) whether it is for SG (OR = 0.66, 95%CI = 0.22-1.97, p = 0.46) or RYGB (OR = 1.05, 95%CI = 0.61-1.81, p = 0.86). Moreover, there was no statistical difference for specific morbidity rate including reoperation, leak, abscess, postoperative bleeding, and late postoperative complications. Limitations Given the